NCT05733780Phase 2Unknown

To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M

Study sponsor: Bioxytran Inc.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-12Estimated
Enrollment · participants40Estimated
Source updated2023-09-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview